About Us Services Products Experience Contact Us

Experience    -    Portfolio

Portfolio
Clients
Testimonials
Substantive Area Client/Project Name Project Type Scope
Alcohol Abuse Addressing the Spectrum of Alcohol Problems (ASAP) Randomized Control Trial Single center, n=340
Autism Collaborative Programs of Excellence in Autism (CPEA) & Studies to Advance Research and Treatment (STAART) Longitudinal Follow up Study
Randomized Control Trial
Multi-center, n=10,500
Two investigations:
n=150 and n=20
Breast Cancer Clinivation, Inc. Longitudinal Follow up Study Multi-center, n=120
Cardiovascular Disease and Medication Compliance Cardiovascular Clinical Studies, LLC (CCS) Randomized Control Trial Multi-center,
Two investigations:
n=70 and n=400
Credentialing and Epidemiologic Monitoring of Nuchal Translucency Nuchal Translucency (NT) Education and Quality Review Program (NTQR) National Quality Review Program Over 2,200 Centers and 4,350 Providers
Diabetes Coached Care for Diabetes Project (CCDP) Longitudinal Follow up Study and Randomized Control Trial Multi-center,
n=900 and n=480
Diseases of Protein Misfolding and Amyloidosis FoldRx and Pfizer Pharmaceuticals, Inc. Longitudinal Follow up Study and Open Label Trials Multi-center,
Four investigations:
between n=25 and n=80 per study
Fertility ReproSource Longitudinal Follow up Study and Clinical Evaluation Multi-center, n=1,100
Fetal Alcohol Spectrum Disorders Fetal Alcohol Spectrum Disorders (FASD) Longitudinal Follow up Study Single center, n=50
HIV and Hepatitis-C HIV Longitudinal Interrelationships of Viruses and Ethanol Study (HIV-LIVE) Randomized Control Trial Multi-center, n=400
HIV and Medication Compliance Medication Adherence in Alcohol Abusing HIV Patients (ADHERE) Randomized Control Trial Single center, n=350
Perinatal Outcomes Perinatal Research Branch (PRB) Longitudinal Follow up Study and Randomized Control Trial Multi-center, n=10,000
Prenatal Diagnosis Artemis Health, Inc. / Living Microsystems Longitudinal Follow up Study and Diagnostic Evaluation Pre-Phase I: n=20;
Phase I: n=140
First and Second Trimester Risk for Aneuploidy (FaSTER) Longitudinal Follow up Study and Clinical Evaluation Multi-center, n=38,000
Fetal Cell Isolation Study (NIFTY I & II) Longitudinal Follow up Study and Diagnostic Evaluation Single center, n=4,000
SIDS and Stillbirth Prenatal Alcohol in SIDS and Stillbirth Network (PASS I & II) Longitudinal Follow up Study Multi-center, n=12,000